secwatch.observer — SEC 8-K summary
======================================

Issuer:     Microbot Medical Inc. (MBOT)
CIK:        0000883975
Form:       8-K
Filed at:   2026-03-24T23:59:59+00:00
Accession:  0001493152-26-012281
Event type: other_material
Sentiment:  positive
Materiality: 0.60
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Microbot Medical's LIBERTY pivotal study published in JVIR; full market launch in April 2026
--------------------------------------------------------------------------------

- ACCESS-PVI study published in JVIR, a top radiology journal, after independent peer review.
- LIBERTY received FDA clearance in Sep 2025; limited market release started late 2025.
- Full commercial launch planned at SIR conference in April 2026 to expand adoption.
- Dr. Francois Cornelis, first author, was Lead PI for the multicenter feasibility study.
- LIBERTY is first FDA-cleared single-use robotic system for peripheral endovascular procedures.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/883975/000149315226012281/0001493152-26-012281-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/883975/000149315226012281/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-012281

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer